News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Healthy lifestyle interventions may be best started in preschool
By Linda Carroll (Reuters Health) - Implementing school-based programs aimed at teaching healthy cardiovascular habits starting in preschool can achieve lasting lifestyle changes in children,
Canada approves Pfizer's oral COVID-19 antiviral treatment, seeks supplies
By David Ljunggren and Ismail Shakil OTTAWA (Reuters) - Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in people aged 18 and older but said
Secondhand vaping linked with respiratory symptoms in young adults
By Linda Carroll (Reuters Health) - Exposure to secondhand vape at home may be linked to a heightened risk for respiratory symptoms in young adults, a new study suggests. An analysis of data from
Pathological complete response likely not a reliable survival surrogate in early breast cancer
By Marilynn Larkin NEW YORK (Reuters Health) - A new meta-analysis suggests that pathological complete response (pCR) should not be used as a surrogate endpoint in randomized trials of neoadjuvant
Vaccine-like mRNA injection effectively treats cardiac fibrosis in mice
By Marilynn Larkin NEW YORK (Reuters Health) - A vaccine-like injection of modified mRNA temporarily reprogrammed immune cells to attack fibroblasts in a mouse model of heart failure, resulting in "
Israeli study shows 4th shot of COVID-19 vaccine less effective on Omicron
By Ari Rabinovitch JERUSALEM (Reuters) - A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it is not enough to prevent Omicron infections, according to a
South African hospital saw less serious disease with Omicron
By Reuters Staff (Reuters) - Doctors in one of the cities where Omicron was first identified say the surge driven by the new variant has been marked by less serious disease than earlier waves of the
Unique strings of molecules may predict variants' success
By Reuters Staff (Reuters) - Researchers believe they have discovered an important way to identify SARS-CoV-2 variants that are likely to spread. Looking at 9-unit strings of nucleotides - the
Lower COVID-19 risks seen after weight-loss surgery
By Reuters Staff (Reuters) - Weight-loss surgery may reduce the risk of severe COVID-19 even if the infected person is still obese after losing weight, according to a report in JAMA Surgery.
Risankizumab effective against refractory psoriatic arthritis
By Matthew Phelan NEW YORK (Reuters Health) - Risankizumab, an inhibitor of interleukin 23, provides some relief for patients with active psoriatic arthritis (PsA) whose symptoms have responded poorly
Good long-term outcomes of kidney/liver transplant in adults with HIV
By Reuters Staff NEW YORK (Reuters Health) - HIV-positive kidney- and liver-transplant patients can expect good long-term outcomes following the transplant, comparable with those of matched
India's Gennova developing Omicron-specific COVID-19 vaccine
By Krishna N. Das NEW DELHI (Reuters) - India's Gennova Biopharmaceuticals is working on an Omicron-specific mRNA COVID-19 vaccine candidate, it told Reuters on Monday, after a person with direct
Moderna CEO says data for Omicron-specific shot likely available in March
By Reuters Staff (Reuters) - Moderna Inc's vaccine candidate against the Omicron coronavirus variant will enter clinical development in the next few weeks and the company expects to be able to share
Germany one step closer to scrapping Nazi-era abortion law
By Reuters Staff BERLIN (Reuters) - Germany's justice ministry presented a draft law on Monday that would do away with a Nazi-era law forbidding doctors to provide information about abortions. Doctors
Schizophrenia tied to increased risk of violence perpetration
By Lisa Rapaport (Reuters Health) - Individuals with schizophrenia spectrum disorders are more likely to perpetrate violence than their counterparts without these conditions, a systematic review and
Experimental drug targets COVID-19 from two angles
By Reuters Staff (Reuters) - An experimental drug originally being developed to treat influenza is showing promise against SARS-CoV-2 and might defend against COVID-19 from two different directions,
Vapers risk more symptoms from COVID-19
By Reuters Staff (Reuters) - E-cigarette users infected with the coronavirus may be more likely than infected non-vapers to experience COVID-19 symptoms, according to research published in the Journal
Many people could still be infectious after 5-day quarantine
By Reuters Staff (Reuters) - After a five-day quarantine, about a third of people infected with SARS-CoV-2 might still be infectious, according to new data. PCR tests detect virus particles but cannot
U.S. judge bars Martin Shkreli from drug industry, orders $64.6 mln payment
By Diane Bartz and Jonathan Stempel WASHINGTON (Reuters) - A U.S. judge on Friday barred Martin Shkreli from the pharmaceutical industry for life and ordered him to pay $64.6 million after he famously
UPDATE 1-U.S. suicide hotline 988 is set to go live, but many states may not be ready
(Adds Lifeline calls in Washington and Wyoming, paragraph 10) By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a
COLUMN-A quiet experiment is testing broader privatization of U.S. Medicare
(The opinions expressed here are those of the author, a columnist for Reuters.) By Mark Miller (Reuters) - Millions of retirees have opted out of traditional Medicare over the past two decades,
FDA approves expanded use of AbbVie's arthritis drug to treat eczema
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration approved the expanded use of AbbVie Inc's arthritis drug to treat eczema, a skin disease, the company said on Friday. The approval of
Humoral response to SARS-CoV-2 infection only slightly lower in liver-transplant patients
By Reuters Staff NEW YORK (Reuters Health) - The humoral response to SARS-CoV-2 infection among liver transplant (LT) recipients is only slightly lower than expected, researchers in the Netherlands
EMA lists rare spinal condition as side effect of AstraZeneca's COVID-19 shot
By Reuters Staff (Reuters) - A safety panel of the European drug regulator on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect of AstraZeneca's COVID-19
J&J booster 85% effective against Omicron hospitalisation, S.Africa says
By Tim Cocks JOHANNESBURG (Reuters) - A Johnson and Johnson COVID-19 vaccine booster shot is 85% effective in protecting against being hospitalised by the Omicron variant for 1-2 months after it is
EU excess deaths in November hit highest in a year - Eurostat
By Reuters Staff (Reuters) - Around 27% more people died in the European Union than usual during November, the biggest increase in a year as a fresh wave of COVID-19 swept the region, official data
Omicron has 1/3 reduced risk of hospitalisation compared to Delta - UK researchers
By Reuters Staff LONDON (Reuters) - There is a one third reduction in the risk of going into hospital associated with the Omicron variant of COVID-19 compared with Delta, researchers at Imperial
S.African study suggests Omicron less severe even for unvaccinated
By Reuters Staff JOHANNESBURG (Reuters) - Unvaccinated people infected with the Omicron variant of coronavirus may be less prone to severe illness and requiring hospital care or dying than was the
U.S. suicide hotline 988 is set to go live, but many states may not be ready
By Barbara Goldberg NEW YORK (Reuters) - In just six months, 988 goes live as the shortcut to call or text the U.S. suicide hotline at a time when the pandemic is ramping up the need for mental health
Peak Omicron? Experts wary of calling time on variant wave in Europe
By Alistair Smout and Nikolaj Skydsgaard (Reuters) - A surge in coronavirus cases caused by the Omicron variant may have peaked in some parts of Europe but medics say the impact will continue to be
FOCUS-Burned by COVID supply crunch, hospitals invest in U.S. mask-making
By Lisa Baertlein (Reuters) - Two days before Christmas, a cargo ship left Mumbai with a mask-making machine bound for Illinois-based OSF HealthCare, which will use the equipment to make its own N95
Anemia in astronauts could be a challenge for space missions
By Harikrishnan Nair (Reuters) - The next "giant leap" for humans may be a trip to Mars, but having enough oxygen-carrying red blood cells for the journey might present a challenge, new research
Short list of smells may diagnose olfactory dysfunction in home test
By Linda Carroll NEW YORK (Reuters Health) - People who are concerned about loss of smell may be able to confirm that loss with a home test that includes the odors of as few as three common household
UK study finds more Omicron hospitalisations in youngest children, but cases mild
By Reuters Staff LONDON (Reuters) - Infants under 12 months of age are proportionally more likely to be hospitalised with the Omicron variant of the coronavirus than older children but they do not
Abdominopelvic surgery risks in pregnancy vary by gestational age, indication
By Reuters Staff NEW YORK (Reuters Health) - Abdominopelvic surgery for non-obstetric reasons is often necessary during pregnancy and the risk of harm to the fetus varies by gestational age,
Dexamethasone effective as an analgesic adjuvant in total knee replacement
By Megan Brooks NEW YORK (Reuters Health) - Two doses of dexamethasone given in the perioperative period reduced morphine consumption during 48 hours after total knee arthroplasty (TKA) and reduced
Transcatheter pulmonary-valve replacement, surgery appear to have comparable outcomes
By Reuters Staff NEW YORK (Reuters Health) - Patients who undergo transcatheter pulmonary-valve replacement (TPVR) face similar odds of surviving and not needing reintervention or surgery as those who
New tool helps predict severe pain during wound dressing changes
By Marilynn Larkin NEW YORK (Reuters Health) - A newly developed tool pinpointed three variables - type of dressing, expected pain and resting pain - that can be used to predict which patients are
Disparities in GLP-1 receptor agonist use in type 2 diabetes
By Lisa Rapaport (Reuters Health) - White and more affluent patients with type 2 diabetes are significantly more likely to receive glucagon-like peptide-1 (GLP-1) receptor agonist therapy than
Incident anorexia among youth increased during COVID-19 pandemic
By Lisa Rapaport (Reuters Health) - The incidence and severity of new-onset anorexia nervosa increased among children and adolescents during the COVID-19 pandemic, a Canadian study suggests.
Court suspends order to wear masks outdoor in Paris - AFP
By Reuters Staff PARIS (Reuters) - A French administrative tribunal on Thursday suspended an order that masks be worn on the streets of Paris, news agency AFP reported. The mask mandate, imposed by
U.S. Supreme Court blocks Biden vaccine-or-test policy for large businesses
By Lawrence Hurley and Andrew Chung WASHINGTON (Reuters) - The U.S. Supreme Court on Thursday blocked President Joe Biden's pandemic-related vaccination-or-testing mandate for large businesses at a
UPDATE 2-U.S. to send 1,000 military health workers, free masks to fight COVID-19
(Adds comments from Biden, details, context) By Susan Heavey WASHINGTON (Reuters) - President Joe Biden on Thursday said he will deploy more military health workers to six U.S. states beginning next
EU court rejects cities' bid to curb car emissions
By Reuters Staff BRUSSELS (Reuters) - The European Union's top court dismissed a complaint on Thursday brought by the cities of Brussels, Madrid and Paris against the European Commission in which they
Biogen seeks dialogue with U.S. CMS about Alzheimer's drug coverage decision
By Manojna Maddipatla (Reuters) - Biogen Inc's chief executive officer on Thursday said the company wants a dialogue with the U.S. Centers for Medicaid and Medicare Services (CMS) ahead of a final
UPDATE 1-U.S. sending 1,000 military health workers to U.S. COVID-19 hot spots
(Updates with news of 500 million more tests) By Susan Heavey WASHINGTON (Reuters) - Another 1,000 military health workers are deploying to six U.S. states beginning next week to help hospitals
S.Africa still seeing serious COVID-19 in unvaccinated, vulnerable during Omicron wave
By Reuters Staff JOHANNESBURG (Reuters) - A South African pulmonologist said on Thursday that she was still seeing serious COVID-19 disease in people who are unvaccinated or have comorbidities during
COVID-19 patients with greatest odds of surviving should get first dibs on scarce ICU beds: survey
By Linda Carroll NEW YORK (Reuters Health) - A new survey finds most Americans are in favor of allotting "the last ICU bed" to the patient with the highest probability of surviving COVID-19. Responses
New data support lowering screening age to 45 for colorectal cancer
By Reuters Staff NEW YORK (Reuters Health) - A new study confirms an increasing incidence of young-onset precancerous colorectal neoplasia among adults younger than age 50 and supports updated
Abiraterone therapy tied to longer survival in Black vs. white men with metastatic castration-resistant prostate cancer
By Lorraine L. Janeczko NEW YORK (Reuters Health) - African American men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone survive longer than their non-Hispanic
Among those under 50, sex rarely leads to sudden cardiac death
By Linda Carroll NEW YORK (Reuters Health) - Sudden cardiac death in those under 50 is rarely associated with sexual activity, a new study finds. An analysis of data from nearly 7,000 cases of sudden
Diverse needs of post-COVID-19 patients managed in or out of the hospital
By Megan Brooks NEW YORK (Reuters Health) - A large study from the UK shows that patients who recover from COVID-19, whether managed in or outside the hospital, often seek care from their primary-care
England's colourful deputy chief medical officer to step down
By Reuters Staff LONDON (Reuters) - England's deputy chief medical officer Jonathan Van-Tam, whose use of colourful metaphors and similes became a hallmark of the British government's COVID-19 news
Poorer nations dump millions of close-to-expiry COVID-19 vaccines - UNICEF
By Francesco Guarascio BRUSSELS (Reuters) - Poorer nations last month rejected more than 100 million doses of COVID-19 vaccines distributed by the global programme COVAX, mainly due to their rapid
AstraZeneca says early trial data indicates third dose helps against Omicron
By Pushkala Aripaka and Ludwig Burger (Reuters) - AstraZeneca said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in neutralising
More U.S. medical teams to bolster states as Omicron surges
By Reuters Staff WASHINGTON (Reuters) - Another 1,000 federal health workers are deploying to six states to help alleviate overwhelmed hospitals amid the U.S. surge in Omicron-related COVID-19 cases,
REFILE-Rates of fatal drug overdose rise during COVID-19 pandemic among men, at-home deaths
(Refiling October 26 story to correct formatting problem experienced by some clients.) By Lisa Rapaport (Reuters Health) - Rates of drug overdose fatalities climbed overall in Rhode Island over the
Long COVID "brain fog" shares features with "chemo brain"
By Reuters Staff (Reuters) - The "brain fog" reported by some people after COVID-19 shows striking similarities to the condition known as "chemo brain" - the mental cloudiness some people experience
Experimental clip-on device finds virus particles in air
By Reuters Staff (Reuters) - A small experimental device designed to be attached to clothing may be able to tell whether the wearer has been exposed to SARS-CoV-2 particles in the air, researchers
Researchers plan for reusing N95 respirator masks
By Reuters Staff (Reuters) - A type of mask used by healthcare providers to protect themselves from the coronavirus can be reprocessed to augment supplies, researchers believe. Unlike cloth and
Pfizer COVID vaccine highly effective at preventing hospitalization in adolescents in real-world study
By Reuters Staff (Reuters Health) - A large real-world study of the two-dose Pfizer COVID-19 vaccine has confirmed that it is highly effective at preventing hospitalizations, the need for intensive
Quebec tax on unvaccinated may be lawful but sets risky precedent - experts
By Anna Mehler Paperny and David Ljunggren TORONTO (Reuters) - A proposal by Quebec to tax unvaccinated people may be lawful but may also go against the spirit of Canada's universal public health
Nine-fold increase in carbon monoxide poisonings after power outages
By Gene Emery (Reuters Health) - A study of long-term power outages in the U.S. has confirmed the widespread suspicion that carbon monoxide emergencies spike after a power outage, and the increase
Pre-omicron study: Vaccines offer 8 months protection from COVID hospitalization
By Gene Emery (Reuters Health) - A North Carolina study of the waning effectiveness of the three COVID-19 vaccines given in the United States shows that although protection against illness from the
FDA flags risk of dental issues from use of opioid addiction drug buprenorphine
By Reuters Staff (Reuters) - The U.S. health regulator on Wednesday warned patients and prescribers about the risk of potential dental problems arising from the use of buprenorphine medicines to treat
Cannabis use associated with elevated cardiovascular disease risk
By Lisa Rapaport (Reuters Health) - Individuals who use cannabis have a higher risk of cardiovascular disease risk factors compared to counterparts who don't use the drug, a recent study suggests.
Omicron less severe than Delta but still poses danger for unvaccinated: WHO
By Reuters Staff (Reuters) - The highly infectious Omicron coronavirus variant causes less severe disease than the Delta strain but it remains a "dangerous virus", particularly for those who are
U.S. COVID deaths rising but likely due to Delta, not Omicron, says CDC chief
By Reuters Staff WASHINGTON (Reuters) - COVID-19 hospitalizations in the United States have increased by about 33% and deaths are up by about 40% from a week earlier, the head of the U.S. Centers for
Expert panel develops quality indicators for diagnosis and treatment of primary hyperparathyroidism
By Megan Brooks NEW YORK (Reuters Health) - An expert panel has developed quality indicators (QIs) for the diagnosis and management for primary hyperparathyroidism (pHPT), which they hope will help
One facemask per week: Valencia health body guilty of neglecting COVID medics
By Reuters Staff MADRID (Reuters) - A Spanish court on Wednesday ordered a regional health authority to compensate scores of doctors for failing to protect them adequately against infection risk
U.S. business fears never ending liability from 'take-home' COVID-19 lawsuits
By Tom Hals (Reuters) - As COVID-19 cases surge in the United States, businesses say they fear a California court ruling has increased the likelihood that companies will be sued for infections, even
Morocco seeks foreign medics to plug pandemic gaps, minister says
By Ahmed Eljechtimi RABAT (Reuters) - Morocco is considering wage hikes for health workers and tax incentives to attract foreign investors and doctors to plug shortages in the health system as it
As Omicron surges, a French hospital creaks under staff shortages
By Antony Paone PARIS (Reuters) - Emergency ward doctor Abigael Debit is increasingly spending her time finding beds for COVID-19 patients, either in her own public-private clinic outside Paris or in
White House taps Inglesby as COVID testing coordinator
By Reuters Staff WASHINGTON (Reuters) - The White House has tapped Dr. Tom Inglesby, the former director of Johns Hopkins Center for Health Security, to lead the government's COVID-19 testing
After initial dip, dementia risk rises with diabetes duration
By Brandon May NEW YORK (Reuters Health) - A new study shows dementia risk follows a U-shape curve after a diagnosis of type-2 diabetes, dropping for nearly five years and then rising again with
Sequential radiation and immunotherapy appears safe
By Reuters Staff NEW YORK (Reuters Health) - Treatment with an immune-checkpoint inhibitor (ICI) within three months following radiation therapy (RT) does not appear to increase the risk of serious
Ireland to give adopted people their records to end 'historic wrong'
By Reuters Staff DUBLIN (Reuters) - Ireland will allow adopted people automatic access to their birth records for the first time under new laws the government hopes will end a "historic wrong",
S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills
By Reuters Staff SEOUL (Reuters) - South Korea is turning to additional pharmaceutical tools as it looks to pre-empt a surge of COVID-19 omicron infections, authorising the use of Novavax Inc's
UPDATE 1-Pfizer study shows COVID-19 booster can be given along with pneumonia shot
By Reuters Staff (Reuters) - Pfizer Inc said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and immune responses in
Drug-eluting stents reduce in-stent restenosis, stroke
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Drug-eluting stents may do a better job reducing in-stent restenosis and stroke recurrence compared with bare-metal stents in patients with
EU drug regulator expresses doubt on need for fourth booster dose
By Reuters Staff (Reuters) - The European Union's drug regulator on Tuesday expressed doubts about the need for a fourth booster dose of COVID-19 vaccine and said there is currently no data to support
UPDATE 1-No vax, pay tax, says Canada's Quebec as health system struggles
(Adds McGill University professor's comment, background) By Ismail Shakil and Anna Mehler Paperny (Reuters) - Quebec, Canada's second most populous province, is planning to force adults refusing to
